Theme: Innovative Therapeutic Strategies in Vaccines & Vaccination

Vaccines Congress 2017
Past Report of Vaccines 2016

Vaccines Congress 2017

Scientific Sessions

Conferenceseries LLC Conferences invites all the participants from all over the world to attend “29th Global Vaccines & Vaccination Summit and Expo” November 30-December 01, 2017. This includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.  The aim of Vaccines Congress is to bring together leading academic Scientists, Researchers, professors, Business delegates, talented student communities and research scholars to commerce and share their experiences and research conclusion about all aspects of Vaccination & Therapeutics research.

Vaccines Congress-2016 hosting presentations from Global Leaders in the field across the Globe and bringing together vaccine stakeholders including academic researchers, public health clinicians, vaccine policy makers, corporate and vaccine manufacturers. There will be opportunities for those selected to present at the meeting to also publish a manuscripts and abstracts from their talk in the Journal of Vaccines and Vaccination or its sister publication Immunome ResearchConferenceseries LLC organizes 1000+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Track 1: Vaccine development:

Vaccine research is long, complex and costly. Because a vaccine is a biological product made from living microorganisms, its development method is quite different from that of a pharmaceutical method. Approximately 70% of production time is dedicated to quality control, Vaccine development is a long, complex process, often lasting 10-15 years and involving a combination of public and private involvement. Vaccine development and testing follow a standard set of steps.

1. Laboratory Studies and Animal Studies: Exploratory Stage, Pre-clinical Stage, IND Application

2. Clinical Studies with Human Subjects: Phase I Vaccine Trials, Phase II Vaccine Trials, Phase III Vaccine Trials,

3. Approval and Licensure

4. Post-Licensure Monitoring of Vaccines

5. Phase IV Trials

VAERS: The Vaccine Adverse Event Reporting System

Related Vaccines Conferences | Vaccines Meetings | Vaccines Congress | World Vaccine Conferences

Geriatric Medicine Conference, Nov 17-19, 2016, USA; 3rd International Conference on Geriatrics & Gerontology, Aug 15-17, 2016, UK; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Australian and New Zealand Society of Geriatric Medicine (ANZSGM) Annual Scientific Meeting 2016, Australia; National Adult and Influenza Immunization Summit Meeting, Georgia; American Geriatrics Society Annual Scientific Meeting 2017, USA; Immunisation of adults and elderly: How to make life course vaccination a successful public health strategy, Poland; 24th Annual Issues & Strategies in Adult Vaccine Preventable Diseases, MN, Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy

Track 2Vaccine Business:

The Evolution in the Vaccines market continues with strong growth and new prospects to continue the growth in Vaccines market, which now stands at about $25 billion. The market is expected to return a compound annual growth rate of more than 8% through 2018, Evaluate projects, with some segments like adult vaccines showing even better.

                           The major growth in vaccine sales has been in the adult influenza market with the big focus on flu prevention and an acceptance of adult vaccines. The Centers for Disease Control and Prevention (CDC) recently noted that only 56% of people who received the jab were protected from influenza, here we present the Top 5 vaccine companies based on their 2012 vaccine revenues, as they are of, Sanofi, Merck, GlaxoSmithKline, Pfizer, Novartis. While vaccine prices have always been higher in the middleeast countries due to tiered pricing, prices have been rising dramatically in recent years.

Related Vaccines Conferences | Vaccines Meetings | Vaccines Congress | World Vaccine Conferences

Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Vaccines R&D-A New Era in Vaccine Discovery Baltimore, USA; 18th Annual Conference on Vaccine Research Bethesda, USA; 13th Vaccines Research & Development: All Things Considered Conference Boston, USA; 16th Annual Conference on Vaccine Research Baltimore, USA; Ebola 2015 Oxford, UK; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016; The Arthropod Vector: The Controller of Transmission (E2), USA; 3rd Conference on Neglected Vectors and Vector-Borne Diseases, Spain, Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy

Track 3: Novel Vaccines against Infectious Diseases:

Vaccination, leading to the eradication of naturally occurring air borne diseases, the near elimination of polio and the control of diseases. The potential introduction of viruses into the sustained circulation among populations of immunologically active, healthy and susceptible hosts. The induction of protective immunity through vaccination by using Vaccines can be a powerful tool to prevent this act by conferring protection to the population at risk is due to the lack of experimental tools for several viruses, lack of concern, poor immunogenicity, safety issues.

Related Vaccines Conferences | Vaccines Meetings | Vaccines Congress | World Vaccine Conferences

Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Vaccine Summit, UK; BIT's 6th Annual World Congress of Vaccine, Dalian, China; New Approaches to Vaccines for Human and Veterinary Tropical Diseases, South Africa; 9th Vaccine & ISV Congress, South Korea; World Vaccine Congress, USA, Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy

Track 4: Adult Immunization Challenges:

Looking forward at vaccine-preventable diseases, findings at the pre vaccine era and the year, you can see virtually that all the vaccine-preventable diseases for which there were current vaccines, they have been decreased by 99% to 100%. we might be forgetting about one of the simplest preventive care measures available is of vaccination. Keeping up to date with your vaccinations is a great way to stay healthy, through the use of vaccines, measles and rubella have been eliminated in many areas, polio has been eliminated from most of the world, and smallpox has been completely eradicated. The reasons for low adult vaccination rates, indicating adult Immunization challenges like one challenge is that payment for adult vaccination can be confusing, the other one is  the adult vaccination schedule is much more complicated than the childhood vaccination schedule, with certain vaccines needed at certain times, depending on age, living conditions and health conditions.

Related Vaccines Conferences | Vaccines Meetings | Vaccines Congress | World Vaccine Conferences

Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Vaccine Summit, UK; BIT's 6th Annual World Congress of Vaccine, Dalian, China; New Approaches to Vaccines for Human and Veterinary Tropical Diseases, South Africa; 9th Vaccine & ISV Congress, South Korea; World Vaccine Congress, USA, Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy

Related Vaccines Conferences | Vaccines Meetings | Vaccines Congress | World Vaccine Conferences

Vaccines have greatly eliminated many infectious diseases that once routinely killed or harmed many infants, children, and adults. Viruses and bacteria that cause vaccine-preventable disease still exist and can be allowed to pass on to people who are not protected by vaccines.  Vaccines work with the body's natural defenses to safely develop immunity and suffering from their effects.     

  Type 1 diabetes is an autoimmune disease which, causes the body’s own ‘killer’ T cells to kill off the pancreas’s insulin which produces beta cells. Diabetes vaccines help to stop the T cells from attacking the body's own cells.

  Type 2 diabetes mellitus is a metabolic disorder results in hyperglycemia (high blood glucose levels) due to the body being ineffective at using the insulin and unable to produce enough insulin,

Type 2 diabetes earlier known as non-insulin dependent diabetes due to its occurrence mainly in people over 40.

Related Vaccines Conferences | Vaccines Meetings | Vaccines Congress | World Vaccine Conferences

Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 11thGlobal Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; RSV vaccines for the World, USA; Influenza Vaccines for the World, Portugal; Pathogenesis of Respiratory Viruses, USA; Influenza Vaccines, Bangkok, Thailand; Third isirv-Antivirals Group Conference: Influenza and Other Respiratory Virus Infections: Advances in Clinical Management, Japan, Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy

Track 6: Veterinary Vaccines:

The major goal of veterinary vaccines is to improve the health and welfare of companion animals, increase production of livestock in a cost-effective way, and prevent animals to human transmission from both domestic animals and wildlife. The strain of rabies virus used and that of the characteristics of the cell substrate chosen for viral replication, highly immunogenic and  inactivated cell culture vaccines for immunization of dogs and the parenteral route are now widely available on the international market at cost affordable. In addition the trend towards transfer of modern cell culture method for the parenteral veterinary vaccine production is increasing in developing countries particularly in Asia.

Related Vaccines Conferences | Vaccines Meetings | Vaccines Congress | World Vaccine Conferences

Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 11thGlobal Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Biomarkers of Vaccine/Adjuvant Potency and Safety, Portugal; Modern Vaccines Adjuvants Formulation, Denmark; The Modes of Action of Vaccine Adjuvants (S1), USA; Modern Vaccines Adjuvants & Drug Delivery Systems, The Netherlands; 4th International Conference: Modern Vaccines/Adjuvants Formulation-Impact On Future Development, Switzerland,Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy

 

Track 7: Therapeutic Vaccines for Chronic Infections:

Therapeutic vaccines mainly aim to prevent severe complications of a chronic infection by reinforcing host defenses when some immune control, albeit insufficient, can be demonstrated using the vaccinia cowpox virus, Jenner was able to protect vaccines from variola or smallpox. The Modified Virus Ankara (MVA) poxvirus strain which is one of the vaccines developed to prevent smallpox infection and was selected by the US government in their Biodefense strategy.

Related Vaccines Conferences | Vaccines Meetings | Vaccines Congress | World Vaccine Conferences

Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 11thGlobal Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Vaccine Technology VI, Portugal; Vaccine Innovation Conference Toronto; Emerging Technologies Conference Cambridge, USA; The Universe of Prefilled Syringes & Injection Devices Vienna, Austria, Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy

Track 8: Cancer Vaccines / AIDS/HIV Vaccines:

HIV vaccine is a type vaccine which would either protect individuals who do not have HIV from contracting that virus, Cancer vaccines are of medicines that belong to a class of substances known as biological response modifiers. This modifiers work by stimulation and restoring the immune system’s ability to fight infections and disease. There are two broad types of cancer vaccines:

2 types of cancer vaccines

1. Preventive (or prophylactic) vaccines

2. Treatment (or therapeutic) vaccines,

Related Vaccines Conferences | Vaccines Meetings | Vaccines Congress | World Vaccine Conferences

Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Vaccines R&D-A New Era in Vaccine Discovery Baltimore, USA; 18th Annual Conference on Vaccine Research Bethesda, USA; 13th Vaccines Research & Development: All Things Considered Conference Boston, USA; 16th Annual Conference on Vaccine Research Baltimore, USA; Ebola 2015 Oxford, UK, Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy

Track 9: Immuno-Informatics in Vaccine Designs:

The regions which are termed as epitopes, are ideal components of vaccines. When the different new tools are used for the search of epitopes, this search is usually coupled with in vitro screening methods; an approach has been termed computational immunology immuno-informatics. The active agent of a vaccine may be intact but it is inactivated (‘attenuated’) forms of the causative pathogens.

Types of vaccines

1.  Inactivated vaccines

2. Live attenuated vaccines

3. Subunit vaccines

4. Virus-like particles

Related Vaccines Conferences | Vaccines Meetings | Vaccines Congress | World Vaccine Conferences

Annual Conference on Virulent HIV Vaccines, July 28-30, 2016 Thailand; Annual Conference on H1N1 & 1Influenza Vaccines, July 25-26, 2016, USA; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA;  HIV Vaccines (X8), USA; HIV Persistence: Pathogenesis and Eradication (X7), USA; American Conference for the Treatment of HIV, USA; The 20th International AIDS Conference, Australia; 2015 National HIV Prevention Conference, USA, Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy

Track 10: Immunology / animal models:

A model organism is a non-human species that is extensively studied to understand particular biological phenomena, with the expectation that discoveries which made in the organism model will provide insight into the different workings of other organisms. It deals with the physiological functioning of the immune system, in states as of both health and diseases, failure of the immune system results in the immunological disorders, which will affect the physical, chemical and physiological characters of the components of the immune system in vitro, in situ and in vivo.

Related Vaccines Conferences | Vaccines Meetings | Vaccines Congress | World Vaccine Conferences

Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Tuberculosis Co-Morbidities and Immunopathogenesis (B6), USA; 5th Asian Vaccine Conference, Vietnam; Tuberculosis Vaccines 2015, Shanghai; 8th International Workshop on Clinical Pharmacology of Tuberculosis Drugs , USA; 46th Union World Conference on Lung Health, South Africa, Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy

Track 11: Vectors / adjuvants / drug delivery:

An adjuvant is any compound that enhances the immune response against a vaccine antigen. In many cases, the antigen itself is immunogenic; therefore an adjuvant is needed to intensify the immune response. Adjuvants can also be included in vaccine, as of which can guide the immune response  which could be generated, Potent adjuvants enhances the effectiveness of vaccines which accelerates  the generation of robust immune responses, the sustaining responses for a longer duration and inducing local mucosal immune responses, thus generating antibodies with increased affinity and neutralization capacity.

Related Vaccines Conferences | Vaccines Meetings | Vaccines Congress | World Vaccine Conferences

Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 11thGlobal Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; The Arthropod Vector: The Controller of Transmission (E2), USA; 3rd Conference on Neglected Vectors and Vector-Borne Diseases, Spain; Emerging Vector-borne Diseases in a Changing European Environment, France; The XIX International Congress for Tropical Medicine and Malaria, Australia; 18th Annual Conference on Vaccine Research, USA, Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy

Track 12: Childhood Immunization Challenges:

The most important challenge today is to keep up the awareness and interest momentum among governments, donors and health personnel until basic immunization services are attained, more than 30 million children still without the most basic protection provided by vaccines. Approximately 40% of children are under immunized state. One of the leading reasons for this is a lack of understanding by parents on the importance of childhood vaccines and lack of importance about vaccines, The primary barrier is of immunization, which we found were parental doubt about vaccine importance, decreased communication with providers, the need to reschedule appointments, and problems scheduling appointments, enhance the immunity.

Related Vaccines Conferences | Vaccines Meetings | Vaccines Congress | World Vaccine Conferences

Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, Chicago, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Melbourne, Australia; Vaccines for Children & Vaccine Preventable Disease Conference South Iselin, NJ; Infectious Diseases in Children A Primary Care and Hospitalist Approach Florida, USA; Colorado Regional Immunization Summit 2015 Grand Junction, CO; 20th Annual Massachusetts Immunization Action (MIAP) Pediatric Immunization Skills Building Conference Marlborough, Massachusetts; GAVI Pledging Conference 2015 Berlin, Germany, Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy

Track 13: Vaccines for pregnant women:

Some of the vaccines, such as the measles, mumps, rubella (MMR) vaccine, should be given a month or more before pregnancy. Vaccines some should get while pregnancy are like T dap which protect against whooping cough, at time during pregnancy. Some other vaccines like the flu shot, can be given before or during pregnancy, which depend upon the whether or not its flu season, when you’re pregnant. There are mostly 2 vaccines routinely recommended during pregnancy time, those are of flu and Tdap.

Pneumococcal vaccine, is used at time, which is high risk of pneumococcal disease

Related Vaccines Conferences | Vaccines Meetings | Vaccines Congress | World Vaccine Conferences

Pregnancy Summit & Child Health, Aug 29-31, 2016, Brazil; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Harmonization Safety Monitoring of Immunization in Pregnancy - International Consensus Conference, USA; Massachusetts Adult Immunization Conference, USA; 2nd IFCC-OCD Conference on Pregnancy Related Disorders, Paris; Safety Monitoring of Immunization in Pregnancy International Consensus Conference, USA; Regional, Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy

 





About Conference

Conferenceseries LLC invites all the participants from all over the world to attend 29th Global Vaccines & Vaccination Summit and Expo” November 30-December 01, 2017.. This includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.  The aim of Vaccines Congress is to bring together leading academic Scientists, Researchers, professors, Business delegates, talented student communities and research scholars to commerce and share their experiences and research conclusion about all aspects of Vaccination & Therapeutics research.

Vaccines Congress-2017 hosting presentations from Global Leaders in the field across the Globe and bringing together vaccine stakeholders including academic researchers, public health clinicians, vaccine policy makers, corporate and vaccine manufacturers. With the generous response and support received from the participants of previous annual vaccines conferences. Conferenceseries LLC organizes 1000+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Why to attend???

Vaccinology/Immunology and its advances, Immunology mainly deals about the structure and function of the immune system. Vaccinology is the science of vaccine development, the participation at this scientific field is your best opportunity to reach the participants from the Immunology/Vaccinology fields from all over the world. It is a global gathering of people from different Immunology areas on to a single platform, conduct presentations, transform information, meet with Eminent and potential scientists, exploring with new vaccines research work and developments, and receive a unique recognition at this event. World-renowned speakers, the most recent techniques, developments in the Vaccines field, discoveries and the current updates and technology in Immunology/Vaccinology are hallmarks of this conference.

Target Audience:

    Vaccinology/Immunology, Scientists
    Vaccinology Researchers
    Vaccinology Faculty
    Medical Colleges Faculty, Students
    Immunology Associations and Societies
    Business Entrepreneurs
    Vaccines Training Institutes
    Software developing companies
    Manufacturing Medical Devices Companies
    Clinical Data Management Companies
    Machinery Manufacturing Companies





Past Conference Report

Euro Vaccines 2016

Conference Series LLC hosted the 10th Euro Global Summit and Expo on Vaccines & Vaccination at Rome, Italy during June 16-18, 2016. The conference was organized with a focus on the theme “Transforming Health through Vaccine Innovations” and was a great success where eminent keynote speakers from various reputed companies and Universities made their resplendent presence and addressed the gathering.

Euro Vaccines 2016 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of Vaccines and Therapeutics.

Conference Series LLC would like to convey a warm gratitude to all the Honorable guests and Keynote Speakers of Euro Vaccines 2016:

Giulio Filippo Tarro, Foundation T. & L. de Beaumont Bonelli for Cancer Research, Italy
Van Regenmortel Marc Hubert Victor, University of Strasbourg, France
Adan Rios, PhotoImmune Biotechnology Inc., USA
Andrew Lees, Fina Biosolutions LLC, USA
Rene Labatut, Sanofi Pasteur, France
Timothy R Fouts, Profectus Biosciences Inc., USA
Prakash Bhuyan, Inovio Pharmaceuticals, USA
Emmanuel Drouet, Université Grenoble-Alpes, France

Conference Series LLC on behalf of the conference, congratulates the Best Poster awardees for their outstanding performance and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavours.

Conference Series LLC also took the privilege of felicitating Euro Vaccines 2016 Organizing Committee, Keynote Speakers, Plenary Speakers, Chairs and Co-Chairs whose support made conference a great success.


Past Reports  Gallery  



Conference Highlights

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date November 30-December 01, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Conferenceseries Destinations